Unknown

Dataset Information

0

Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization.

ABSTRACT:

SUBMITTER: Jeong SW 

PROVIDER: S-EPMC7576090 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization.

Jeong Soung Won SW  

Annals of translational medicine 20200901 18

Similar Datasets

Unknown The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
| S-EPMC7214899 | biostudies-literature
Unknown Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma.
| S-EPMC8201147 | biostudies-literature
Unknown Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
| S-EPMC8342583 | biostudies-literature
Unknown Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
| S-EPMC6520830 | biostudies-literature
Unknown Transarterial chemoembolization for hepatocellular carcinoma.
| S-EPMC3036492 | biostudies-literature
Unknown The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
| S-EPMC8774110 | biostudies-literature
Unknown Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
| S-EPMC5369882 | biostudies-literature
Unknown A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.
| S-EPMC4412579 | biostudies-literature
Unknown Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization.
| S-EPMC6305141 | biostudies-literature
Unknown Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.
| S-EPMC7198364 | biostudies-literature